| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | 0.44 | 0.01 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.079 | 0.01 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |